Top compounds associated with response to RP11-343C2.9


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC -0.098 0.008
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.009
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.009
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.095 0.01
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.01
mRNA TAE684 CTRPv2 pan-cancer AAC -0.092 0.01
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.01
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.086 0.01
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.13 0.01
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.01
Download CSV